Lastly, a different study found that NEK4 knockdown in lymphoma promoted cellular microtubule stability in the presence of chemotherapeutic agents Taxol and Vincristine, making NEK4 a potentially selective marker for treating chemotherapy-resistant lymphoma based on patient-specific expression levels [7]. Here, NEK4 is linked to lymphoma.